chrisvoncsefalvay/vaers-outcomes huggingface dataset:
i got fever; pain in the body; colitis; felt like had been run over by a train; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced fever (Verbatim: i got fever), general body pain (Verbatim: pain in the body), colitis (Verbatim: colitis) and feeling unwell (Verbatim: felt like had been run over by a train). The outcome of the fever, general body pain, colitis and feeling unwell were not reported.   It was unknown if the reporter considered the fever, general body pain, colitis and feeling unwell to be related to Shingles vaccine.     It was unknown if the company considered the fever, general body pain, colitis and feeling unwell to be related to Shingles vaccine.   Additional Information: GSK receipt date:02-JUL-2023 This case was reported by a patient via interactive digital media. The reporter had heard that the vaccine was great.he/she got vaccinated, and had a fever, pain in the body, even colitis, he/she felt like he/she  had been run over by a train. The reporter thanked God that he/she was already vaccinated.  Follow-up would not be possible as no contact details were available.
Abdominal pain; Adrenal nodule; Calculus of gallbladder without cholecystitis without obstruction; Hepatomegaly; Right upper quadrant abdominal pain
I woke up nauseous, when I stood up extremely nauseous.  Went to feed dog and passed out without warning and woke up to my head slamming on floor.  Stood up and immediately passed out again, again waking up to my head slamming on floor.  Got a bunch of bumps and bruises on head but hurt my neck also.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's concomitant medications, pertinent medical history, concurrent conditions, drug reactions or allergies were not reported. On 05-OCT-2017, the patient was vaccinated with one dose of ZOSTAVAX 19400 PFU, lot # N012614 expiration date 16-MAR-2018, via the intramuscular route instead of the recommended subcutaneous route, for prophylaxis. The vaccine was reconstituted with sterile diluent (MRK) (lot # N015478 exp 28-SEP-2019). Adverse events were not reported.
Patient received 2nd dose of Pfizer COVID19 vaccine on 1/29/21.  Patient reported COVID like symptoms on 4/10/21 after having a known exposure.  Patient tested COVID positive 4/13/21
This spontaneous report as received from a registered nurse refers to a 17 month old patient. The medical history, concurrent conditions and concomitant medications were not reported. On 27-OCT-2016, the patient was vaccinated with an improperly stored doses of (Oka/Merck) VARIVAX lot # M027347, 01-JUN-2018 and (wistar ra 27-3) M-M-R II M032153 22-APR-2017. No adverse effects were reported. Additional information has been requested.
No adverse effects were reported; Patients were administered improperly stored vaccines doses; This spontaneous report was received from a registered nurse, concerning a patient of unspecified age and gender. The patient's pertinent medical history, concurrent conditions, drug reactions, allergies and concomitant medications were not reported.   On 11-APR-2019, the patient was vaccinated with improperly storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) for prophylaxis, lot #R034700 and expiration date 16-JUN-2020 (strength, dose, frequency and route of administration were not reported); with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) for prophylaxis, lot #R033080 and expiration date 06-JUN-2020 (strength, dose, frequency and route of administration were not reported); and with hepatitis a vaccine, inactivated (VAQTA) for prophylaxis lot #S001485, expiration date 12-MAY-2020 and lot #R012988 and expiration date 30-MAY-2019. No adverse effects were reported.   The temperature excursion was reported as below 36°F (35.4°F) during a time frame of 27 minutes. Previous temperature excursion was reported as below 36°F (35.4°F) during a time frame of 15 minutes.   A digital data logger was involved.   This is one of several reports received from the same  reporter.; Sender's Comments:  US-009507513-1904USA012221: US-009507513-1905USA002744: US-009507513-1905USA002745: US-009507513-1905USA002747: US-009507513-1905USA002748: US-009507513-1905USA002749: US-009507513-1905USA002750: US-009507513-1905USA002751: US-009507513-1905USA002752: US-009507513-1905USA002753: US-009507513-1905USA002754: US-009507513-1905USA002755: US-009507513-1905USA002756: US-009507513-1905USA002757: US-009507513-1905USA002758: US-009507513-1905USA002759: US-009507513-1905USA002760: US-009507513-1905USA002761: US-009507513-1905USA002762: US-009507513-1905USA002763: US-009507513-1905USA002764: US-009507513-1905USA002765: US-009507513-1905USA002766: US-009507513-1905USA002767: US-009507513-1905USA002768: US-009507513-1905USA002769: US-009507513-1905USA002770:
About 11 days after vaccination,  patient developed  signs and symptoms of peripheral neuropathy in hands and feet that were getting worse every day, burning and tingling with pins and needles, excruciating pain and paralysis of  limbs. Dx Gillian Barre.
Nausea and low grade fever the first day. Headache, low grade fever, minor congestion,, and fatigue the next two days.
9/30 Pt reports weakness, decreased appetite, and dry mouth ongoing x 2 weeks, diarrhea COVID Results + Acute COVID 19 infection.  No evidence of pneumonia.
joint pains & fever p/1st dose; hospitalized; RIG given p/hospitalized; really sick described by mom; now gets fever p/each dose; scratched by a rabid cat; treatment initiated 3 wks p/incident; 15DEC92 f/u no info on ADE; pt had jaw pain
Soreness and tightness at injection site for the first 2 days. Itchiness following for about 2 days and now have red bumps/rash on and around injection site without itchiness, a week after the first injection.
After a very deep cut on my leg, I needed stitches. I went into the er. Dr  was the attending, he suggested a tetanus shot since my leg was cut outdoors doing yard work. I clarified several times "tatanus only right" to which him and several nurses replied yes.  Several times. After reviving the shot I was told it was dtap. I left. After receiving this shot, without my consent, I walked home. That night, I lost the function of both my legs for a week. I'd fall while walking. Increasingly leg weakness. Also, that night I began having panic attacks every night for 3 years now. Also that night, my jaw locked up. I've been fighting TMJ symptoms every single day, all day, since 10 pm the night the shot was given. I'm still fighting panic occasionally. My life has become unmanageable from the symptoms.
Bad side effects; This case was reported by a consumer and described the occurrence of adverse event in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was not recovered/not resolved.   It was unknown if the reporter considered the adverse event to be related to Shingrix.  Additional information received were as follows: The age at vaccination was not reported. The patient was having bad side affects after receiving Shingrix.
Severe pain in whole arm, rash, pt has had difficult sleeping - pt has been taking Tylenol, Aleve, Ibuprofen q4-6h, No relieves
Pt recv vax on 2/23/98; 35 min post vax pt exp dizziness, nausea, vomiting, substernal chest pain to LA, diaphoresis
Information has been received from a healthcare worker (office manager) referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (lot # L044694, expiration date 04-FEB-2018; dose and route were unknown). No symptoms were reported. The vaccines were stored under 1 degree Centigrade for 6 days in November 2015, 1 degree Centigrade for 20 days in December 2015, 1 degree Centigrade for 16 days in January 2016, 1 degree Centigrade for 20 days in February 2016 (totally 62 days). No other excursions were involved. This is one of several reports received from the same reporter. Additional information has been requested.
Dose 1: 1/4/2021 Soreness at injection site within 6 hrs that resolved after 48 hrs, one week later swollen armpit and discomfort in the same injected arm that went away after approximately 48 hrs  Dose  2:  2/1/2021  Soreness at injection site within 4 hrs, chills and generalized malaise and head ache that same night and sore throat, stuffiness that is ongoing  at 24 hrs.
Individual complain of soreness and 1 inch lump under the left arm with a fever of 103 degrees Fahrenheit.
Sore shoulder starting about 3 PM 06/23/2022.  Fatigue, achy joints starting about 7 PM 06/23/2022.  Symptoms continued into 06/24/2022.  Mild headache developed about 11 AM 6/24/2022; treated with 1 aspirin.  Except for the sore shoulder, none of these symptoms developed from the 3 Moderna shots earlier.
Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021; Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021 at 2:28 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Feb-2021 at 2:28 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 42.20 years.  Concomitant products were not provided.  On 09-Feb-2021, vaccines with batch number 031L20A were moved to the fridge. On 12-Feb-2021, three vials were moved to clinic. On the same day at 09 AM, vials underwent temperature excursion with temperature 29 degrees Fahrenheit and between 10 AM to 11 AM vials underwent temperature excursion with temperature 35 degrees Fahrenheit. The condition of vaccine prior to vaccination was not frozen. The vaccine beyond use date was reported as 10-Mar-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  It was reported that, the patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021. The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree Fahrenheit.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
11/28/21 - chills, fatigue, body aches 11/29/21 - chills fatigue, body aches 11/30/21 - chest pain, shortness of breath, pleuritic chest pain 12/1/21 - chest pain resolved
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. No concurrent conditions, medical history and concomitant medications were reported. On 13-MAR-2016 the patient was vaccinated with first dose of GARDASIL 9 (unspecified lot and expiration date) (dosing regimen and frequency unknown). On 14-MAR-2016 and 13-MAY-2016 the patient was vaccinated with second and third doses of GARDASIL 9 (unspecified lot and expiration date) (dosing regimen and frequency unknown). No adverse effects reported. No product quality complaint (PQC) filed. Additional information has been requested.
Pt stated right arm sore starting eve of flu shot 9/28/2016. We recoreded shot being given in left arm.
Pt called office on 11/12 (3 days after receiving vaccine) and stated that her right upper arm was swollen, red, painful, warm to the touch, had a rash and itched. Measured approximately 3 inches by 4-5 inches. The area was wrapping around to the back of her arm. Pt states she thought it would get better after it started, but it had been getting worse. Patient received Haemophilus Influenzae Type B (R upper) and TD/Tdap (R lower) in that arm.  Scheduled pt for clinic appt on 11/13 afternoon. Pt called 11/13 to cancel appt, stating that her right arm where she got the injections had improved and does not feel needs to be seen today. Pt states the site is not hot and not nearly as red.  Pt was not seen by physician. Was instructed to call office if arm worsens or with any concerns.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 12-OCT-2012 at 00:02, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Got the flu in January, which gave me a cough (no other symptoms). Tested negative for COVID. The cough has continued, fluctuating in severity from minor annoyance to particularly difficult since then (it is currently nearly May).
Erythematous swelling left arm arm puncture site (DTaP) non-tender.
After 10 minutes of vaccine, patient started to have tight chest, and numbness on opposite arm. Then she couldn't remember her name and date of birth for 5 minutes. She then felt her throat was swelling. 911 was called and paramedics checked her blood pressure and vitals were within range. She was monitored at the hospital and was doing fine.
Body aches and severe headache. These are known side effects, but the physician I contacted said he had never heard of a 10/10 headache from the vaccine.
The evening after I administered PMEUMOVAX 23 by IM into the patient's left deltoid (three fingerbreadths down from the acromion process but above the armpit, she experienced arm pain which grew in severity over the night and prevented her from lifting her left arm for the next two days. There was no redness or induration at the site.
IUP at 39. 5 weeks; admitted for elective induction.  Incidental COVID-19 positive finding. Asymptomatic.
from her knees down down she started to get hive like bumps on legs that were itchy and lasted about 3 days; from her knees down down she started to get hive like bumps on legs that were itchy and lasted about 3 days; rash; red bumps came out again but those are now on her arms as well; WBC was up; This is a spontaneous report from a contactable consumer or other non hcp. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection) via an unspecified route of administration on 29Apr2021 as 2nd Dose, Single Dose for COVID-9 immunization.The patient's medical history included autoimmune disorder.The patient's concomitant medications were not reported.She has an autoimmune disease and initially after receiving the first dose, she had a questionable severe allergic reaction.She received the vaccine on a Thursday and then on Sunday had shortness of breath and heart palpitations which lasted for 3 days and went away.The patient reported she received her second dose 3 weeks later on 29Apr2021, which was also a Thursday , and had no issues but then about 6 or 7 days later from her knees down, she started to get hive like bumps on legs that were itchy and lasted about 3 days and took care of it on own with topical cream, 10 days after that the rash came back, her pulmonologist did normal blood work and thought caller thought her eosinophils  were reacting but they were normal but WBC was up and the red bumps came out again but those are now on her arms as well. She went to the dermatologist, and is being treating with a steroid cream. She read on line that there have been reactions of hive like symptoms. The outcome for the events was recovered/resolved for hives, itchy skin and Unknown for other events.  Information on Lot/Batch number has been requested.
having a little itchiness,  little breaking out of  the tiny bit by the site ( Injection site); incision  injection swollen a just  little bit/noticed the incision that swollen up little bit; Slightly little itchy throat; Slightly itchy eyes; Another spot come  by itchy.; Injection incision that swollen up little bit; Flat hives/Couple of hives at injection site; This is a spontaneous report from a contactable consumer reporting for herself. A 72-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 72 years old on 20Apr2021 15:00 on left upper arm at single dose for COVID-19 immunization. Medical history included High Blood pressure, Kidney stones, Mild Asthma, Allergies and Urinary tract infection. Concomitant medications included amlodipine besilate, hydrochlorothiazide, olmesartan medoxomil (TRIBENZOR) for High blood pressure. The patient previously took Olmesartan along with amlodipine, hydrochlorothiazide for high blood pressure. Patient stated "Slight itching and I am concerned because I do have allergies. And I can take EpiPen just in case. EpiPen for allergic reaction. I have one if in case this getting worse. its just  little itchy right now. Just telling you that I do have one, no, of course no, not yet because I am only experiencing a little itchiness and a little breaking out tiny only little bit, slightly little itchy throat, slightly itchy eyes which is I wanna make sure in another words some one would be able to use the information and Pfizer can also tell me how to deal with it." For LOT number (second dose) patient stated "I can't tell you if it is EW0171 OR TW0170. I am confused with first letter of LOT#." For Lab test patient stated "Yes 2 weeks ago (2021) and everything was fine." Patient also stated "Yes just one second its not bad its like injection site is weird and itchy than another spot come  by itchy. yes I can't really right now. my daughter noticed the incision that swollen up little bit and it was swollen up first, I wiped it with band aid early today with little alcohol so that no infection from my hand touching it. than I said  my god I am not supposed to scratch that." "It is just same when I called you actually I did noticed the incision injection swollen a just  little bit and I am having a flat hives couple of hives at the injection site and I noticed my eyes was little bit itchy about 30 minutes ago, I didn't rubbed them but they were feeling a little of itchy you know I started realizing hey wait a minute this is one of the symptom that they say if anybody, on the news if anybody has these should report  may be nothing to be done, may be it get worst or may be call (with held). I just wanted to report that I am having allergies. I have mild asthma. not right now but I do have mild asthma. it is so mild that rarely ever have to use inhalers (further clarification unknown) may be once a week four months." The events were happened in Apr2021. The outcome of the events were unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Received MMR and Varivax 10/18/04.  On 10/29/04 returned to office with both erythematous, macular eruption to trunk and pruritic vesiculo-papular eruption to face, trunk and extremities.
Information has been received from a pharmacist via a company representative referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were unknown. On an unknown date, the patient was vaccinated with ZOSTAVAX (0.65 ml, subcutaneous) for prevention of shingles. On an unknown date, unspecified time post vaccination, the patient developed shingles. The outcome of the event was unknown. The causality was not provided. Additional information has been requested.
Shot received 10/01/21. Symptoms of muscle aches started that night. The next day, slight fever, some body aches, and painful swelling of a lymph under my left arm pit. Painful swelling continues.
pt recvd vax & 4hrs post vax exp fever,chills,nausea,malaise,inj site pain;sx resolved w/in 48hrs;
lump under her armpit; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-Jun-2021 and was forwarded to Moderna on 07-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (lump under her armpit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (lump under her armpit). At the time of the report, AXILLARY MASS (lump under her armpit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter.  Treatment information was not provided.  Additional information reported include that the patient had lump under the armpit for 3 weeks.
From December 1, 2016 ongoing to today May 9,2017 I have experienced persistent skin rashes on both legs, arms, shoulders and ankle to a full body eruption with hives and rashes that ooze and bleed, fever, chills, joint pain, clothing sensitivity, severe itching, swollen lips, swollen arms with limited mobility and hard lumps on the arms hot to the touch, disrupted sleep and an immune system feeing compromised allowing a case of bronchitis and earache and general lack of energy. The most adverse issues were experienced starting March 1 2017 to March 31, 2017. KENALOG injections were helpful along with antihistamines, Hydroxyzine Pamoate, Prednisone, and Levocetirizine. On February 24, 2017 Terbinafine was prescribed for my ankle and leg.
Pt received the vaccine when it was out of its best use date period. The expiration date was 10/2023 but it has been in the fridge for over 10 weeks.
Active 70 year old. Experiencing shortness of breath when walking up a flight of stairs. Walking and talking creates a strain on breathing.